Sir,
Fuchs endothelial corneal dystrophy (FECD) has a significant genetic component to its pathogenesis and several genetic risk factors for FECD have been discovered. The first genetic risk factor for FECD, transcription factor 4 (TCF4), was detected by a genome-wide association study.1 A trinucleotide repeat, (CTG)n also known as CTG18.1, is located within an intron of the TCF4 gene.2 Expansion of the TCF4 trinucleotide repeat is associated with FECD and expansion to >40 repeats confers a hazards ratio of 1.64 for a corneal transplant.3 Anticipation, earlier onset of disease with increasing severity in successive generations, occurs in diseases caused by trinucleotide repeat expansions (ie, Huntington’s disease).4
Case report
We investigated the potential role of TCF4 trinucleotide repeat expansion in a three-generation pedigree with a history suggestive of anticipation. FECD was diagnosed via slit lamp biomicroscopy by a board-certified ophthalmologist with cornea fellowship training, graded using a modified Krachmer scale of 0 (no disease)–6 (>5 mm of central confluent guttae with corneal edema),5 and examined via confocal microscopy (ConfoScan 4, Nidek Technologies, Fremont, CA, USA) and corneal tomography (Pentacam HR, Oculus, Lynnwood, WA, USA).
Three family members were diagnosed with FECD5 and displayed features of anticipation. The age at diagnosis occurred earlier in each successive generation, with the grandmother, mother, and daughter receiving the diagnosis of FECD at 63, 48, and 27 years of age, respectively (Figures 1 and 2). The severity of corneal endothelial disease was greater in each successive generation, with the grandmother, mother, and daughter displaying a modified Krachmer Grade of 2, 4, and 6, respectively, and central corneal thickness (right/left) of 535/537, 568/572, and 627/602 μm, respectively.
The size of the TCF4 trinucleotide repeat was evaluated in members of the FECD pedigree to determine if an expansion of the repeat might be the source of anticipation. The TCF4 trinucleotide repeat was amplified from family member DNA samples with the polymerase chain reaction, cloned, and sequenced using standard methods.6 Each family member’s genome has two copies of the TCF4 gene. Analysis of these DNA sequences revealed the exact number of TCF4 trinucleotide repeats in each family member’s genome. The grandmother, mother, and daughter had 19 and 28, 19 and 26, and 24 and 26 CTG repeats in TCF4 genes, respectively (Figure 1).
Comment
All three family members with FECD had <40 TCF4 trinucleotide repeats. While larger numbers of TCF4 trinucleotide repeats confer higher risk for FECD, 20% of patients with FECD have fewer than 40 repeats as in this pedigree.2 Moreover, there is no expansion of TCF4 trinucleotide repeats in successive generations of the pedigree (Figure 1). These data demonstrate that anticipation of FECD in this pedigree is not due to trinucleotide repeat expansion in the TCF4 gene. The earlier age at diagnosis and severity of FECD in offspring of this pedigree may be due in part to ascertainment bias and/or other genetic and environmental factors. However, the TCF4 trinucleotide repeat may underlie anticipation in other FECD pedigrees with patients that have larger numbers of repeats than were observed in this study.
References
Baratz KH, Tosakulwong N, Ryu E, Brown WL, Branham K, Chen W et al. E2-2 protein and Fuchs’s corneal dystrophy. N Engl J Med 2010; 363 (11): 1016–1024.
Wieben ED, Aleff RA, Tosakulwong N, Butz ML, Highsmith WE, Edwards AO et al. A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS One 2012; 7 (11): e49083.
Eghrari AO, Vasanth S, Wang J, Vahedi F, Riazuddin SA, Gottsch JD . CTG18.1 expansion in TCF4 increases likelihood of transplantation in Fuchs corneal dystrophy. Cornea 2017; 36 (1): 40–43.
MacDonald ME, Ambrose CM, Duyao MP, Myers RH, Lin C, Srindhi L et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. The Huntington’s Disease Collaborative Research Group. Cell 1993; 72 (6): 971–983.
Krachmer JH, Purcell JJ, Young CW, Bucher KD . Corneal endothelial dystrophy. A study of 64 families. Arch Ophthalmol 1978; 96 (11): 2036–2039.
Hazlewood RJ, Roos BR, Solivan-Timpe F, Honkanen RA, Jampol LM, Gieser SC et al. Heterozygous triplication of upstream regulatory sequences leads to dysregulation of matrix metalloproteinase 19 (MMP19) in patients with cavitary optic disc anomaly (CODA). Hum Mutat 2015; 36: 369–378.
Acknowledgements
This research was funded in part by Research to Prevent Blindness Physician Scientist Award and by Leonard and Marlene Hadley.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Greiner, M., Terveen, D., Vislisel, J. et al. Assessment of a three-generation pedigree with Fuchs endothelial corneal dystrophy with anticipation for expansion of the triplet repeat in the TCF4 gene. Eye 31, 1250–1252 (2017). https://doi.org/10.1038/eye.2017.60
Published:
Issue Date:
DOI: https://doi.org/10.1038/eye.2017.60
This article is cited by
-
A large multi-ethnic genome-wide association study identifies novel genetic loci for intraocular pressure
Nature Communications (2017)